2024 NEWS
National Academy of Inventors Stony Brook Receives Chapter of Excellence Award
Wei Zhao (center) receiving the NAI Chapter of Excellence Award from Elizabeth Dougherty,
Eastern Regional Outreach Director, and Paul R. Sanberg, president, National Academy
of Inventors. (Read more)from Stony Brook News July 22, 2024
New Drug to Control Pain Related to Cancer Treatment Originally Developed at Stony Brook Gets FDA Clearance
Six years ago Stony Brook University through the Research Foundation for the State
University of New York licensed a promising technology to Artelo Biosciences that identified Fatty Acid Binding Proteins (FABPs) as drug targets of the body’s
endocannabinoid system for a potentially promising way to treat pain, inflammation
and cancer. Now the first one of these compounds has been cleared by the Food and
Drug Administration (FDA) for human clinical trials. Artelo announced this week that
the FDA’s initial approval of one of the FABP5 (5 indicates a specific protein) selective
compounds called ART26.12 enables the company to initiate its first human phase 1
single ascending dose study of the drug. The company states that ART26.12 will address
a critical need for cancer patients, treating chemotherapy-induced peripheral neuropathy.
Phase 1 clinical trials are expected to be launched internationally during the first
half of 2025. The work on FABPs originated with Iwao Ojima, PhD, SUNY Distinguished Professor in
the Department of Chemistry at Stony Brook University, Martin Kaczocha, PhD, Associate
Professor in the Department of Anesthesiology in the Renaissance School of Medicine
at Stony Brook University, and Dale Deutsch, PhD, Professor Emeritus in the Department
of Biochemistry and Cell Biology at Stony Brook University, a research collaboration
affiliated with the ICB&DD. They identified the action of FABPs as drug targets.
Specifically, FABP5 was identified as the intracellular transporter for the endocannabinoid
anandamide (AEA), a neurotransmitter produced in the brain that binds to cannabinoid
receptors. (Read more)from Stony Brook News July 17, 2024.
Dr. Carol Crater Elected to US National Academy of Sciences
Dr. Carol Carter, a Distinguished Professor in the Departmet of Microbiology and
Immunology at the Stony Brook University Renaissance School of Medicine, has been
elected a member of the U.S. National Academy of Sciences (NAS). Carter is the 18th
Stony Brook University faculty member elected to the NAS, and is only the second elected
member from the Renaissance School of Medicine.
(Read more) from SBU News
Ojima Distinguished Lectureship Award in Chemistry - Dr. Hiroaki Suga, Honoree (2024)
The Institute of Chemical Biology and Drug Discovery (ICB&DD), Department of Chemistry,
College of Arts and Sciences and Office of the Provost hosted the “Distinguished Lectureship
Award in Chemistry”, honoring distinguished lecturer Dr. Hiroaki Suga on April 26,
2024. The event took place in the Charles Wang Center, SBU. (Read more) from SBU news
To view photo albun of this event, click the link below
https://photos.app.goo.gl/C7J6kWsMsBx7tzs58
https://photos.app.goo.gl/RV8sqjuXzJ1Xd2TE6
NAI-SBU Announces the 2024 Young Academic Inventor's Award Winners (read more)
2023 NEWS
TVM Capital Life Science (TVM) is Committing up to $24 million for a Development Program to Advance NE-DHA-SBT 1214, Dr. Iwao Ojima's Compound, to Market for the Treatment of Colorectal Cancer and Other Solid Tumors
For the past few decades, Dr. Iwao Ojima has been working in his Stony Brook University Department of Chemistry Laboratory
and through the Institute of Chemical Biology & Drug Discovery (ICB&DD) to develop next-generation anti-cancer agents. One of these agents – a second-generation
taxane conjugate in a nanoemulsion formulation (called NE-DHA-SBT-1214) – has shown
great promise against solid tumors – particularly against colorectal cancer. The taxane
compounds were licensed to a Stony Brook University spinout, TargaGenix, Inc., in
2016, to advance their development toward clinical use. Since then, TargaGenix has
further developed the compounds, addressing formulation, toxicity and in vivo efficacy,
and has now attracted significant investment into NE-DHA-SBT-1214. TargaGenix plans
to work with its partners to develop the new taxane as a stand-alone drug, as well
as look to use it in combination with other treatment modalities, including immune-oncology
agents. The company and its collaborators expect to advance the drug development into
clinical testing in humans in the near future. (Read more) from SBU News (Read more) from InnovateLI.com news
Dr. Yuanyuan Yang Elected 2022 NAI Fellow
Dr. Yuanyuan Yang received her Ph.D. and M.S. degree in computer science from Johns Hopkins University. She graduated from Tsinghua University in China and obtained her M.S. in computer science and engineering and her B.Eng. in computer science and engineering. She is currently a SUNY Distinguished Professor in the Department of Electrical & Computer Engineering and Department of Computer Science at Stony Brook University, where she joined in 1999. From 2018-2022, she served as a program director in the National Science Foundation's Directorate of Computer and Information Science and Engineering. She directed the core computer architecture program and was on the management team of several cross-cutting programs. At Stony Brook, she served as the Associate Dean for Diversity and Academic Affairs of College of Engineering and Applied Sciences from 2016-2018, a Division Director of New York State Center of Excellence in Wireless and Information Technology (CEWIT) from 2007-2016 and the Graduate Program Director of Electrical & Computer Engineering Department from 2001-2016. Prior to joining Stony Brook in 1999, she held a tenured faculty position at University of Vermont. Dr. Yang is internationally recognized for her contributions in parallel & distributed computing systems and networking. She was named an IEE Fellow through Computer Society in 2009 and in 2022 she won the Outstanding Service Award of the IEE Computer Society Technical Committee on Distributed Processing. In over 30 years, Yuanyuan Yang has been credited with many breakthrough results and innovative inventions in the field of interconnection networks. In particular, her series of work on non-blocking Clos multicast networks has made foundational contributions to the interconnection network field. Her seminal patents/papers on this work along with subsequent work have opened up new areas of innovations and research in multicast interconnection networks with direct applications to many today’s emerging areas, such as voice/video switching, optical networking, parallel computer interconnecting and data center networking. This series of work has been extensively cited and included in many books on the subject that are widely used by researchers and teachers. Based on the patented idea in her patent US 8,107,468, Media Global Links built "MD10000" IP video router, which was adopted by a major Japanese broadcaster FUJI Television Network in 2008. The video router has been running by FUJI for 14 years, generating tremendous lasting impacts on quality of life, economic development, and the welfare of society, and has been reported in multiple media channels.
(read more)from SBU news
2022 NEWS
Dr. Marie Badalamante, Keynote Speaker at the NAI-SBU 2022 Young Academic Symposium Award: "From Bench to Bedside or How I Got From Here to There"
Dr. Stanislaus Wong, Keynote Speaker at the NAI-SBU 2022 Annual Meeting: "Rationally Designed Nanowires as Catalysts for Energy Applications"
NAI-SBU Announces the 2022 Young Academic Inventor's Award Winners, (read more)
Drs., Lei Wang and Yasha Karimi
2021 NEWS
Drs. Craig Lehmann and Serge Luryi Elected 2021 NAI Fellows.
Dr. Craig Lehmann is a registered clinical chemist and a Fellow in the National Academy of Clinical
Biochemistry. He is also Dean of the School of Health Technology and Management at
Stony Brook University. As Dean and Professor, Dr. Lehmann leads Undergraduate and
Graduate Programs for Clinical Laboratory Sciences; Respiratory Care; Physician Assistant;
Cytotechnology; Occupational Therapy; Physical Therapy; Health Sciences and Healthcare
Policy and Management. Under his direction, the School of Health Technology and Management
is now the largest of all of the health professions schools at Stony Brook University.
For the past several years, Dr. Lehmann has participated in national and international
conferences, lecturing on emerging technologies that improve the aging experience.
Dr. Lehmann presented at Capitol Hill in Washington, D.C., where he led President
Bush’s Advisor for Science and Technology in discussions that focused on the benefits
of e-technology and the major disease states suited for application; principally,
diabetes, cardiovascular disease and congestive heart failure. To that end, he invented
a medication management device that assists clients and caregivers managing complex
medication regimens and may help reduce the $100-300 billion spent in the U.S. each
year for medication non-adherence issues. The medication manager is licensed to a
Long Island start-up company. Dr. Lehmann’s research, publications, and presentations
on clinical education span many years. He served for three years on the Editorial
Board for the American Association for Clinical Chemistry’s Strategies and Solutions. He is also a member of the Editorial Board of Clinical Laboratory Sciences since 1987. In addition to authoring more than 65 journal articles, Dr. Lehmann is
the author, editor and/or co-editor of five clinical laboratory science textbooks,
which include the “Saunders Manual of Clinical Laboratory Science, Clinical Laboratory
Instrumentation: Theory, Practice and Costs”, “W.B. Saunders and Clinical Diagnostic
Technology: the Total Testing Process”, a three volume series by the American Association
for Clinical Chemistry. Dr. Lehmann has also contributed nine book chapters and produced
a four-part educational video entitled, "Automation in the Clinical Laboratory" published
by W.B. Saunders. He has presented over 125 presentations, worldwide, on clinical
analysis by computer assisted infrared spectroscopy, clinical laboratory education,
workflow analysis, laboratory economics, e-health, point of care testing and disease
management. Dr. Lehmann has also served as a United States delegate for the American
Society for Clinical Laboratory Sciences at three world congresses in Holland, Sweden,
and Australia. He is the recipient of many awards including the “Outstanding Contributions
in Education Award from the American Association for Clinical Chemistry, and the Stony
Brook University Provost's Award for "Exceptional Service to Undergraduate Education"
at Stony Brook University.
Dr. Serge Luryi is a Distinguished Professor of the SBU department of Electrical and Computer Engineering.
He is also a Fellow of the American Physical Society, and a Fellow of the Optical
Society of America. In 1994, Dr. Luryi joined the faculty of Stony Brook University
where he was appointed as Distinguished Professor, the highest-ranking professorship
in the State University of New York system. From 1994 to 2016 he served as Chair of
Electrical and Computer Engineering. Since 1998, he has been the Founding Director
of the New York State Center for Advanced Technology in Sensor Systems (Sensor CAT).
The Sensor CAT was driven by needs of New York State industries that develop, manufacture,
or employ sensors and supported science-based start-ups, especially those connected
with university research. This support included universal modern prototyping facilities,
assistance by the CAT’s Entrepreneur-in-Residence, and the CAT’s connections with
the New York investment community. The Sensor CAT has developed an “All in One” Electrical
Engineering Educational Kit, including laboratories, which allowed Stony Brook University
to become the first research institution to offer a Bachelor of Science in Electrical
Engineering online degree. Since its inception in 1998 the Senor CAT has received
over $20M in funding from NY State, which enabled Dr. Luryi and his team to develop
splendid research facilities at the Sensor CAT. Most of this activity was based
on the patented inventions of Dr. Luryi and his associates in such diverse sensor-related
fields as DNA sequencing and high-energy radiation detection. A preeminent research
scientist, Dr. Luryi was elected to the Fellow of the IEEE for contributions in the field of heterojunction devices, Fellow of the American Physical Society for theory of electron transport in low-dimensional systems and invention of novel
electron devices, and Fellow of the Optical Society of America for outstanding and pioneering contributions to semiconductor optoelectronics, especially
to the physics and photonic applications of low-dimensional semiconductor structures. In 2006, he received the IEEE Long Island Section's Papoulis Award for Excellence
in Engineering and Technology Education with the citation: "For pioneering contributions to include entrepreneurial skills in engineering education
on Long Island." Dr Luryi served on the Editorial Board of the IEEE Transactions on Electron Devices, first as an Associate Editor and then as Editor. He is also the Founding Director
of the triennial advanced research workshop on Future Trends in Microelectronics. During his tenure, Dr Luryi has published over 250 papers and has been awarded 54
US patents in the areas of high-speed electronic and photonic devices, material science,
sensor systems and electronic packaging. Dr. Luryi’s most impactful invention to
industry and society is the endowment of silicon chips with various capabilities,
e.g. optoelectronics. In his impressive career, Dr. Luryi has been a pioneer in
semiconductor research and its commercial application by translating research discoveries
into new technologies.
From Stony Brook News: https://news.stonybrook.edu/university/serge-luryi-and-craig-lehmann-elected-2021-fellows-of-the-national-academy-of-inventors/
The 2021 NAI Fellow list includes 164 prolific innovators from 116 research universities, and governmental and non-profi t institutes worldwide. They collectively hold 4,800 issued U.S. patents. List of 2021 NAI-Fellows at NAI
NAI-SBU Announces the 2021 Young Academic Inventor's Award Winners , (read more)
Drs., Andrew LaBella, Sina Rashidian and Andrew Fesler.
Dr. Jahangir Rastegar, Keynote Speaker at the NAI-SBU 2021 Annual Meeting: "An Inventor's Experience"
Congratulations to Professor Iwao Ojima Elected to European Academy of Sciences
Professor Ojima will be honored at the induction ceremony of new members at EurASc’s Annual Symposium and Ceremony of Awards event this April at the Sorbonne University in Paris, France, which will be held virtually due to the COVID-19 (Read more)
2020 NEWS
The Stony Brook University Chapter of the National Academy of Inventors proudly announces the winners of the 2020 “Young Academic Inventor’s Award”.
Cogratulations to: Drs: Priyanka Sharma, Adrian F. Howansky, Michael Ferdman and Peter Milder (read more)
2019 NEWS
Dr. Israel Kleinberg and Stanislaus Wong Elected 2019 NAI Fellows.
Dr. Israel Kleinberg and Stanislaus Wong Elected 2019 NAI Fellows
Congratulations to Drs. Kleinberg and Wong for being selected to the rank of Fellows of the National Academy of Inventors (NAI). (Read more)
Israel Kleinberg
Stanislaus S. Wong
2018 NEWS
The Stony Brook University Chapter of the National Academy of Inventors Proudly Announces the of the 2018 "Young Academic Inventor's Award", (from left to right Drs: Amirhossein Goldan, Dmytro Gudkov and Ming-yu Ngai). Read more
New Members Inducted at the Stony Brook University Chapter of the National Academy of Inventors Annual Meeting 2018
SOM Dean Kenneth Kaushansky selected Fellow of the National Academy of Inventors
Kenneth Kaushansky MD, MACP, Senior Vice President of the Health Sciences and Dean of the Renaissance School of Medicine, has been selected as a Fellow of the National Academy of Inventors. Election as an NAI Fellow is the highest professional distinction accorded to academic inventors who have demonstrated a prolific spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on the quality of life, economic development and welfare of society. (Read more).
2017 NEWS
Dr. Arie Kaufman and Clinton Rubin Elected 2018 NAI Fellows
Arie Kaufman, PhD, Distinguished Professor of Computer Science, and Clinton Rubin, PhD, Distinguished Professor of Biomedical Engineering in the College of Engineering and Applied Sciences at Stony Brook University have been elected as Fellows of the National Academy of Inventors (NAI).
According to the NAI, election as an NAI Fellow is a high honor bestowed upon academic innovators and inventors who have demonstrated a prolific spirit of innovation in creating or facilitating outstanding inventions and innovations that have made a tangible impact on quality of life, economic development, and the welfare of society. Professors Kaufman and Rubin will be inducted as NAI Fellows during its 2018 national meeting in Washington, DC, on April 5. (read more).
The Stony Brook University Chapter of the National Academy of Inventors Proudly Announces the Inaugural Winners of the "Young Academic Inventor's Award", (from left to right Drs: Martin Kaczocha, Luisa Escobar-Hoyos and Joseph Merino). Read more
New Members Inducted at the Stony Brook University Chapter of the National Academy of Inventors Annual Meeting 2017
2016 NEWS
Dr. Lorne Golub Inducted Fellow of the National Academy of Inventors
Congratulations to Dr. Lorne Golub for being selected to the rank of Fellow of the National Academy of Inventors (NAI). The NAI Selection Committee has chosen Dr. Golub for induction as he has demonstrated a highly prolific spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on quality of life, economic development, and the welfare of society. Dr. Golub was congratulated by the NAI on this great achievement and recognition as a truly prolific academic inventor. Dr. Golub is to attend the Fellows Induction Ceremony on April 6, 2017 at the John F. Kennedy Presidential Library & Museum in Boston, MA. Dr. Golub is a Distinguished Professor in the Department of Oral Biology and Pathology. He has published over 300 peer-reviewed papers and monographs in various dental, medical and biological journals, and has over 55 patents issued. He is also the lead inventor of zinc-binding, sub-antimicrobial dose tetracycline ; Periostat® (for treatment of gum disease) and Oracea® (for treatment of rosacea), both have been marketed by Galderma.
Distinguished Professor Benjamin Hsiao Named Invention Ambassador
Benjamin Hsiao, Distinguished Professor of Chemistry at Stony Brook University, has been selected as a member of the American Association for the Advancement of Science (AAAS)-Lemelson 2016-17 Class of Invention Ambassadors. More
Congratulations to Drs. Lorne Golub, Francis Johnson and Maria Ryan, Investigators of a newly funded grant from the National Institute of Dental and Craniofacial Research (NIDCR) to advance treatment of Periodontal Disease.
The funding is intended to further evaluate the pre-clinical safety and effectiveness of the Traverse’s leading drug candidate, TRB-N0224, for the treatment of periodontal disease. See more
Dr. Jahangir Rastegar Inducted Fellow of the National Academy of Inventors
NAI-SB congratulates Dr. Jahangir Rastegar for being recently inducted as a Fellow of the National Academy of Inventors. Dr. Rastegar was inducted as a new Fellow of the National Academy of Inventors on April 15, 2016 as part of the Fifth Annual Conference of the National Academy of Inventors at the United States Patent and Trademark Office (USPTO) in Washington DC. In honor of their outstanding accomplishments, Fellows are presented with a special trophy, medal, and rosette pin. Election to NAI Fellow status is a high professional distinction given to academic inventors who have demonstrated a very prolific spirit of innovation in creating or facilitating outstanding inventions that have made a significant impact on quality of life, economic development, and welfare of society.
